Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Harvey

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The Personnel Journal|April 11, 1983
Two alternatives to traditional sick leave programsB H Harvey
Medical Hypotheses|June 22, 2000
Acid-dependent dismutation of nitrogen oxides may be a critical source of nitric oxide in human macrophagesB H Harvey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 1, 1997
The neurobiology and pharmacology of depression. A comparative overview of serotonin selective antidepressantsB H Harvey
Occupational Health; a Journal for Occupational Health Nurses|October 1, 1972
The right to work in safetyB H Harvey
Behavioural Brain Research|June 7, 2000
Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatmentB H Harvey, A Bester
IBRO Neuroscience Reports|October 7, 2022
Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatmentK Mncube, B H Harvey
Behavioural Pharmacology|June 12, 2003
Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapineA Nel, B H Harvey
International Clinical Psychopharmacology|December 1, 1996
Phasic craving for carbohydrate observed with citalopramC D Bouwer, B H Harvey
Metabolic Brain Disease|June 1, 2001
Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movementsA M Bester, B H Harvey
Clinical Neuropharmacology|May 10, 2000
Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitorsB H Harvey, C D Bouwer
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Personnel Journal|April 11, 1983
Two alternatives to traditional sick leave programsB H Harvey
Medical Hypotheses|June 22, 2000
Acid-dependent dismutation of nitrogen oxides may be a critical source of nitric oxide in human macrophagesB H Harvey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 1, 1997
The neurobiology and pharmacology of depression. A comparative overview of serotonin selective antidepressantsB H Harvey
Occupational Health; a Journal for Occupational Health Nurses|October 1, 1972
The right to work in safetyB H Harvey
Behavioural Brain Research|June 7, 2000
Withdrawal-associated changes in peripheral nitrogen oxides and striatal cyclic GMP after chronic haloperidol treatmentB H Harvey, A Bester
IBRO Neuroscience Reports|October 7, 2022
Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatmentK Mncube, B H Harvey
Behavioural Pharmacology|June 12, 2003
Haloperidol-induced dyskinesia is associated with striatal NO synthase suppression: reversal with olanzapineA Nel, B H Harvey
International Clinical Psychopharmacology|December 1, 1996
Phasic craving for carbohydrate observed with citalopramC D Bouwer, B H Harvey
Metabolic Brain Disease|June 1, 2001
Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movementsA M Bester, B H Harvey
Clinical Neuropharmacology|May 10, 2000
Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitorsB H Harvey, C D Bouwer
Pageof 3